弹和降落方法溶解Piroxicam;其在不可逆转过程的热力学上的现象学模型
Momoko Fujita1, Tomohiro Tsuchida1, Hikaru Kataoka1
1Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
International journal of pharmaceutics
|October 30, 2024
概括
像普拉诺洛尔这样的小分子可以充当"降落发电机",稳定超和药物溶液. 这项研究阐明了这种效应背后的机制,这对于改善药物溶解和输送至关重要.
科学领域:
- 制药科学 制药科学
- 物理化学 物理化学
- 药物运输 药物运输 药物运输
背景情况:
- "弹和降落"方法通过使用各种配方来增强溶解性较差的药物的溶解.
- 这种方法的精确机制,特别是"降落发电机"的作用,需要进一步阐明.
- 之前的工作确定了氧气布洛卡因作为皮洛西卡姆的降落发生器.
研究的目的:
- 探索用于稳定超和药物状态的小分子降落发生器.
- 为了研究醇对Piroxicam的降落效应.
- 为了阐明降落效应的运动控制机制.
主要方法:
- 研究了兰醇对皮洛西卡姆过状态的影响.
- 研究了甲和迪布卡因度对皮罗西卡姆溶解状态的影响.
- 分析了晶体的转化 (无水化到单水化) 和奥斯瓦尔德的成熟动态.
主要成果:
- 普罗普拉诺洛尔在过的皮洛西卡姆上表现出降落效应.
- 甲 (10毫米) 和迪布卡因 (2.5毫米) 的特定度也表现出降落效应.
- 降落发电机动力稳定了皮洛西卡姆的超和状态.
- 奥斯瓦德的成熟导致了晶体的变化和超和状态的减弱.
结论:
- 小分子,如醇,四甲和迪布卡因,可以作为降落发生器.
- 这些发电机通过保持稳定状态来稳定超和药物溶液.
- 了解奥斯瓦尔德成熟是充分解释效应及其局限性的关键.
相关概念视频
Theories of Dissolution: The Danckwerts' Model and Interfacial Barrier Model
276
Various dissolution theories provide insight into the factors that influence the dissolution rate. Danckwerts' Model suggests that turbulence, rather than a stagnant layer, characterizes the dissolution medium at the solid-liquid interface. In this model, the agitated solvent contains macroscopic packets that move to the interface via eddy currents, facilitating the absorption and delivery of the drug to the bulk solution. The regular replenishment of solvent packets maintains the...
276
Theories of Dissolution: Diffusion Layer Model
697
Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
697
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
179
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
179
Factors Influencing Drug Absorption: Drug Dissolution
423
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
423
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
288
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
288


